Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-02

Clinical Trial Update: Validation of α-synuclein Modifications in Parkinson's dIsoRder Evolution

View source ↗

Summary

This entry notes a recruiting clinical trial investigating α-synuclein modifications in the evolution of Parkinson disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Casa di Cura IGEA | Conditions: Parkinson Disease (PD) | Status: RECRUITING